{"id":"W2472847770","doi":"10.1200/jco.2015.65.1901","title":"Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":243,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Medical Research Council; National Health and Medical Research Council; Bayer HealthCare","keywords":"Regorafenib; Medicine; Internal medicine; Hazard ratio; Placebo; Ramucirumab; Clinical endpoint; Performance status; Gastroenterology; Adverse effect; Chemotherapy; Surgery; Cancer; Randomized controlled trial; Confidence interval; Colorectal cancer; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017881,0.0001409536,0.001657074,0.0001366863,0.00006046637,0.000003646547,0.0001444058,0.0001338952,0.0003282773],"category_scores_gemma":[0.003736228,0.0000556058,0.001115532,0.0001194342,0.0001496039,0.00007024648,0.00001741397,0.0001496519,0.000001718636],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003109613,"about_ca_system_score_gemma":0.001177296,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001211127,"about_ca_topic_score_gemma":0.00004770048,"domain_scores_codex":[0.9970683,0.0001619125,0.002105797,0.0001498772,0.0003148124,0.000199305],"domain_scores_gemma":[0.9891377,0.007716355,0.00227856,0.0001553341,0.0005623925,0.0001496299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4623931,0.00374201,0.0007145185,0.000006034595,0.0008510071,0.00001719661,0.00003987077,0.00001620936,0.0001412823,0.0000852917,0.00382604,0.5281674],"study_design_scores_gemma":[0.6683713,0.0888701,0.002430691,0.00005076547,0.001336658,0.00001387207,0.00007683118,0.0001996656,0.00006891214,0.00009785646,0.2384371,0.00004629585],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9361039,0.001388851,0.003862269,0.05120435,0.004071545,0.002864747,0.0000256403,0.000009163725,0.0004695654],"genre_scores_gemma":[0.9767584,0.005370339,0.003622545,0.0006271299,0.003765459,0.0002696481,0.000002147209,0.00001697238,0.009567353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5281212,"threshold_uncertainty_score":0.4472884,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1183170464801156,"score_gpt":0.494835759791865,"score_spread":0.3765187133117494,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}